找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cell and Gene Therapies; Miguel-Angel Perales,Syed A. Abutalib,Catherine Bo Book 2019 Springer Nature Switzerland AG 2019 Chimeric antigen

[复制链接]
楼主: 鸟场
发表于 2025-3-26 23:28:36 | 显示全部楼层
Dave Cowan,Helen Carr,Alison Wallace the only therapy that has proven to be curative for hematological malignancies. The search for a more specific and, hopefully, less toxic therapeutic approach using immune system cells that are redirected toward the target of interest is needed and ongoing. This could be potentially accomplished by
发表于 2025-3-27 01:47:13 | 显示全部楼层
发表于 2025-3-27 05:33:49 | 显示全部楼层
Cell and Gene Therapies978-3-319-54368-0Series ISSN 2569-1376 Series E-ISSN 2569-135X
发表于 2025-3-27 12:24:14 | 显示全部楼层
发表于 2025-3-27 16:30:52 | 显示全部楼层
Most Recent Clinical Advances in CAR T Cell and Gene Therapy 2017/2018,ogenic disorders (Gardner et al., Blood 129:3322–3331, 2017) (refer to subsequent disease-specific chapters in the book). In this chapter, we will highlight the most recent and clinically relevant developments in the arena of gene-modified T-cell-based therapies and hematopoietic stem cellular gene
发表于 2025-3-27 18:50:43 | 显示全部楼层
Chimeric Antigen Receptor T Cells for Leukemias in Children: Methods, Data, and Challengesgation for treatment of relapsed ALL. Whole-genome sequencing has allowed characterization of the transcriptional profile of the leukemic cell, facilitating targeted therapy and leading us one step closer to precision medicine. In this rapidly evolving “race” for better and nontoxic treatments, we f
发表于 2025-3-27 22:04:29 | 显示全部楼层
发表于 2025-3-28 03:14:01 | 显示全部楼层
Cytotoxic T Cells for Infections: From Donor Specific to “Off the Shelf”the deficiencies in viral immunity post-transplant. In this review, we begin by detailing the advances made in producing single-virus-specific T cells, in particular for CMV and EBV, and then proceed to describe the progress in developing multi-virus-specific T cells and in broadening the repertoire
发表于 2025-3-28 09:48:06 | 显示全部楼层
Regulatory T Cells: Broadening Applicability even prevent this fatal complication in the clinical setting. Ultimately, researchers and clinicians want to find a way to establish long-lasting tolerance within the graft without diminishing the beneficial graft-versus-tumor/graft-versus-leukemia (GvT/GvL) effect..The chapter will give an overvie
发表于 2025-3-28 11:38:39 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 21:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表